Talc Pleurodesis With Intense 18F-FDG Activity But No 68Ga-DOTA-TATE Activity on PET/CT

被引：5

作者：

Papadakis, Georgios Z. ^{[1
]}

Millo, Corina ^{[2
]}

Bagci, Ulas ^{[1
,3
]}

Patronas, Nicholas J. ^{[1
]}

Stratakis, Constantine A. ^{[4
]}

机构：

[1] Warren Grant Magnuson Clin Ctr, Radiol & Imaging Sci, Orlando, FL 32835 USA

[2] NIH, Div Nucl Med, RAD&IS, Ctr Clin, Orlando, FL USA

[3] Univ Cent Florida, Ctr Comp Vis Res, Orlando, FL 32816 USA

[4] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA

来源：

CLINICAL NUCLEAR MEDICINE | 2015年 / 40卷 / 10期

关键词：

POSITRON-EMISSION-TOMOGRAPHY; FDG-PET/CT; PLEURAL METASTASES; SOMATOSTATIN; EXPRESSION; GRANULOMA; PATIENT; CT;

D O I：

10.1097/RLU.0000000000000807

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Talc pleurodesis (TP) is a technique, widely employed in the management of patients with persistent pleural effusions or pneumothoraces not amenable to other treatment options. It is well documented that talc deposits produce areas of highly increased F-18-FDG uptake, because of talc-induced inflammation. We present a case of a patient with history of TP who was evaluated with both F-18-FDG and Ga-68-DOTA-TATE. The hypermetabolic area seen on F-18-FDG-PET-CT in the region of talc placement showed no uptake by Ga-68-DOTA-TATE, suggesting the potential role of Ga-68-DOTA-TATE-PET-CT in elucidating F-18-FDG-postitive lesions in patients with history of both neuroendocrine malignancy and TP.

引用

页码：819 / 820

页数：2

共 50 条

[1] 68Ga-DOTA-TATE PET-CT in differentiated thyroid cancer patients: comparison with 18F-FDG PET-CT
Vatankulu, B.
Akovali, B.
Sager, S.
Halac, M.
Kabasakal, L.
Sonmezoglu, K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S223 - S223
[2] A Comparison of 68Ga-DOTA-TATE and 18F-FDG PET/CT Imaging on Patients with Pancreatic Neuroendocrine Neoplasm (pNEN)
Zhang, P.
Yu, J.
Lu, M.
Shen, L.
Yang, Z.
Li, J.
NEUROENDOCRINOLOGY, 2017, 105 : 178 - 178
[3] Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors
Abdulrezzak, Ummuhan
Kurt, Yurdagul K.
Kula, Mustafa
Tutus, Ahmet
NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (08) : 874 - 881
[4] 68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Epithelioid Hemangioendothelioma Comparison With 18F-FDG
Derlin, Thorsten
Hueper, Katja
Soudah, Bisharah
CLINICAL NUCLEAR MEDICINE, 2017, 42 (11) : E478 - E479
[5] Standardizing image quality for 68Ga-DOTA-TATE PET/CT
Cramer, M.
van Lierop, S. Z. M.
Cox, C. P. W.
Segbers, M.
Valkema, R.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S670 - S670
[6] Standardized image quality for 68Ga-DOTA-TATE PET/CT
Cox, Christina P. W.
Segbers, Marcel
Graven, Laura H.
Brabander, Tessa
van Assema, Danielle M. E.
EJNMMI RESEARCH, 2020, 10 (01)
[7] Standardized image quality for 68Ga-DOTA-TATE PET/CT
Christina P. W. Cox
Marcel Segbers
Laura H. Graven
Tessa Brabander
Daniëlle M. E. van Assema
EJNMMI Research, 10
[8] Metastatic prostate adenocarcinoma with neuroendocrine differentiation on 18F-FDG PET/CT, 68Ga-PSMA PET/CT and 68Ga-DOTA TATE PET/CT with injected ultra-low-activity
Zhang, Y.
He, Y.
Yu, H.
Shi, H.
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2022, 46 (5-6): : 224 - 226
[9] 68Ga-PSMA HBED-CC PET/CT imaging may be useful in detection of differentiated thyroid cancer: a comparative study with 68Ga-DOTA-TATE PET/CT and 18F-FDG PET/CT imaging
Vatankulu, B.
Akgun, E.
Ocak, M.
Demirci, E.
Uslu, L.
Sager, S.
Halac, M.
Kabasakal, L.
Sonmezoglu, K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S70 - S70
[10] 68Ga-DOTA-IBA PET/CT and 18F-FDG PET/CT in Ewing Sarcoma
Xiang, Feifan
Liu, Huipan
Tan, Xiaoqi
Ma, Wenzhe
Chen, Yue
CLINICAL NUCLEAR MEDICINE, 2024, 49 (11) : 1036 - 1038

← 1 2 3 4 5 →